Medican Enterprises, Inc.
MDCN
$0.00
$0.000.00%
OTC PK
| 03/31/2015 | 12/31/2014 | 09/30/2014 | 06/30/2014 | 03/31/2014 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 6.03% | 15,573.33% | 96,652.52% | 126,144.63% | 337,901.10% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.03% | 15,573.33% | 96,652.52% | 126,144.63% | 337,901.10% |
| Operating Income | -6.03% | -15,573.33% | -96,652.52% | -126,144.63% | -337,901.10% |
| Income Before Tax | -338.16% | -14,916.31% | -82,591.38% | -95,950.98% | -155,277.78% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -338.16% | -14,916.31% | -82,591.38% | -95,950.98% | -155,277.78% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -338.16% | -14,916.31% | -82,591.38% | -95,950.98% | -155,277.78% |
| EBIT | -6.03% | -15,573.33% | -96,652.52% | -126,144.63% | -337,901.10% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -17.17% | -11,421.15% | -66,240.18% | -82,129.87% | -142,745.95% |
| Normalized Basic EPS | -16.96% | -11,413.52% | -66,178.83% | -81,492.78% | -140,463.83% |
| EPS Diluted | -17.17% | -11,421.15% | -66,240.18% | -82,129.87% | -142,745.95% |
| Normalized Diluted EPS | -16.96% | -11,413.52% | -66,178.83% | -81,492.78% | -140,463.83% |
| Average Basic Shares Outstanding | 176.12% | 55.09% | 34.84% | 16.52% | 2.74% |
| Average Diluted Shares Outstanding | 176.12% | 55.09% | 34.84% | 16.52% | 2.74% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |